caris life sciences ipo - Search News

News

Life Sciences, AI and IPO

Seeking Alpha · 3h

Caris Life Sciences: Momentum Returns In The IPO Market

Caris Life Sciences is experiencing rapid growth, leveraging AI and molecular science for personalized medicine. Click here to find out why CAI stock is a Hold.

Fast Company on MSN · 2d

Caris Life Sciences IPO: All eyes on the stock price today as the AI cancer care firm makes its Nasdaq debut

The cancer diagnostics and treatment company priced shares above their earlier target range and might signal a renewed appetite for biotech listings. On Wednesday morning, the cancer diagnostics biotech firm Caris Life Sciences rang Nasdaq’s opening bell in New York,

The Dallas Morning News on MSN · 2d

Caris Life Sciences spikes by over 30% in IPO debut, embraces AI as future of oncology

The stock of Caris Life Sciences shined in its Nasdaq debut on Wednesday, pricing its heavily-subscribed initial public offering at $21 per share and

Caris settles IPO at $21, trading starts at $28

Despite raising the price of its IPO twice, Caris Life Sciences Inc. left money on the table with a 33% increase in price as ...

2d

Caris Life Sciences Announces Pricing of Initial Public Offering

Caris Life Sciences® (Caris), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, ...

Caris swells its planned IPO, seeking $5.7bn valuation

The IPO comes just a few weeks after Caris raised $168 million in a private financing round that took the total raised by the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results